Journal profile · Agricultural and Biological Sciences-Food Science
PharmaNutrition
ISSN 2213-4344 · eISSN 2542-520X · Elsevier
PharmaNutrition: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.9 (journal website); hybrid open access; APC about USD 3,300; review about 143 days (submission to acceptance, publisher); 34 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
PharmaNutrition is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 25% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
PharmaNutrition is the truly multidisciplinary home for preclinical and clinical researchers in academia and industry, working at or close to the interface of nutritional and pharmacological treatment concepts: where “nutrition” (food, food ingredients, specialized enteral and parenteral nutrition) and “pharma” (pharmacological intervention, clinical studies) meet, including the combination of the two. The journal is published quarterly.
From the journal's Aims & Scope
Research area (LetPub): Agricultural and Biological Sciences-Food Science
Editor-in-chief Laura Rubió PiquéPublisher website
Editorial board by country: 3 in mainland China (about 7%); most named Italy 10, Spain 8, Canada 5, Mainland China 3, United States 3 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.5%
- Human auditory perception and evaluationEngineering8.3%
- Educational Robotics and EngineeringComputer Science8.2%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology7.1%
- Diet and metabolism studiesMedicine6.1%
- Fatty Acid Research and HealthNursing5.6%
- Natural Antidiabetic Agents StudiesMedicine5.5%
- Phytochemicals and Antioxidant ActivitiesMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Nutrition & Dietetics | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Nutrition & Dietetics | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.9Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher)
- 5.1Publisher website ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 202OpenAlex ·
- 2-year mean citedness
- 2.94OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 23.08%LetPub ·
Volume
- Articles per year
- 29LetPub ·
Articles by year OpenAlex count · 637 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 65 | 5 | 22 |
| 2025 | 34 | 8 | 144 |
| 2024 | 47 | 15 | 263 |
| 2023 | 39 | 10 | 291 |
| 2022 | 36 | 15 | 401 |
| 2021 | 28 | 8 | 492 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
143 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to first decision
- 24 daysPublisher website ·
- First decision after review
- 68 daysPublisher website ·
- Submission to acceptance
- 143 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,300 / EUR 3,090 / GBP 2,640 / JPY 409,300 | — | — | |
| Publisher website | USD 3,770 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
- Not considered
- in vitro antioxidant activity; MDA data
Article types accepted7
- commentaryRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
- editorialRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
- regular paperRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
- research paperRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
- reviewRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
- review articleRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
- systematic reviewRegular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2213-4344
- Electronic ISSN
- 2542-520X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about PharmaNutrition
What CAS zone is PharmaNutrition in?
In the 2025 upgraded edition of the CAS Journal Ranking, PharmaNutrition is in Zone 4 of Medicine, and in Zone 4 of the minor category Nutrition & Dietetics / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of PharmaNutrition?
The journal's website gives an impact factor of 2.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 5.1, h-index 40.
How long does peer review take at PharmaNutrition?
The publisher reports about 143 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of PharmaNutrition?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of PharmaNutrition based?
Of the 45 board members whose country the journal's board page names, 3 (about 7%) are in mainland China; the countries named most often are Italy (10), Spain (8) and Canada (5). Counted from the institutions listed on the board page; for reference only.
Which databases index PharmaNutrition?
According to LetPub and DOAJ records, PharmaNutrition is indexed in ESCI and Scopus.
Is PharmaNutrition open access, and what is the APC?
PharmaNutrition is a hybrid journal. For open-access publication: APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .